H.R. 1796Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Progress: Introduction / referral onlyLatest action: Referred to the House Committee on Energy and Commerce.
119th CongressPolicy area: Health
- Troy A. CarterOriginal cosponsorMar 3, 2025
Official CRS summary
Official CRS summary (Introduced in House version) · Congress.gov(opens in a new tab)
This bill reauthorizes through FY2029 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve prevention and treatment of sickle cell disease and complications from the disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)